Company Profile For Genzyme Corporation

Genzyme Corporation (Genzyme) is a biotechnology company. Genzyme operates in four segments: Genetic Diseases, Cardiometabolic and Renal, Biosurgery and Hematologic Oncology. Genetic Diseases unit develops, manufactures and distributes therapeutic products, with a focus on products to treat patients suffering from genetic diseases and other chronic debilitating diseases, including a family of diseases known as lysosomal storage disorders (LSDs). Cardiometabolic and Renal segment develops, manufactures and distributes products that treat patients suffering from renal diseases, including chronic renal failure and endocrine and cardiovascular diseases. Biosurgery segment develops, manufactures and distributes biotherapeutics and biomaterial-based products, with a focus on products that meet medical needs in the orthopaedics and broader surgical areas. Hematologic Oncology segment develops, manufactures and distributes products for the treatment of cancer.

BRIEF: For the nine months ended 30 September 2009, Genzyme Corporation's revenues rose less than 1% to $3.43B. Net income rose 19% to $399.1M. Revenues reflect higher revenues from Cardiometabolic and Renal, increased income from Biosurgery segments and higher revenue from Hematologic oncology segment. Net income also reflects a decrease in research and development expenses and the presence of gain on acquisition of business.